Oracle launches new version of clinical development analytics

Wednesday, March 28, 2012 11:42 AM

Oracle Health Sciences has introduced the newest version of Oracle Health Sciences Clinical Development Analytics in an effort to help health sciences organizations increase the productivity and effectiveness of their product development programs.

Driven by input from industry partners, the updated application includes new functionality that expands visibility into clinical programs and studies, improves the quality and timeliness of clinical trial data and helps simplify and prioritize the responsibilities of study managers, clinical data managers and site monitors.

The application comes with more than 100 pre-built reports and over 500 pre-built measurements and attributes for custom reporting. It also provides advanced dashboard tailored to clinical trial roles, featuring key performance indicators that identify areas requiring action or attention, such as targeting underperforming sites.

In addition, the solution enables organizations to merge data from multiple clinical trial sources, providing a unified view across operational systems on a single screen. New de-duplication technology supports reports that combine both clinical operations and data management information to monitor enrollment progress, optimize productivity at site visits and help to reduce monitoring-related travel expenses.

The solution is accessible at all times through the Oracle Business Intelligence Mobile application for iPhones and iPads.

Share:          
CWWeekly

April 20

Christie Clinic, PMG Research's 12th clinical research site, expands its geographic reach north to Illinois

Clinipace acquires Accovion to expand European presence, following an infusion of equity that could lead to more deals

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

PSI, INC Research, Chiltern best with sites
Strategic outsourcing prioritizing, improving site relationships

Regulatory compliance an increasing burden on sites
Increased staff time, materials, storage eroding site operating profit

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs